Patents by Inventor Karlheinz Grillitsch

Karlheinz Grillitsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230257792
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Application
    Filed: September 12, 2022
    Publication date: August 17, 2023
    Applicants: BOEHRINGER INGELHEIM RCV GMBH & CO KG, LONZA LTD., VALIDOGEN GMBH
    Inventors: Karlheinz Grillitsch, Guenther Daum, Andreas Grutsch
  • Patent number: 11479798
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: October 25, 2022
    Assignees: BOEHRINGER INGELHEIM RCV GMBH & CO KG, SANDOZ AG, VALIDOGEN GMBH, BIOMIN HOLDING GMBH, LONZA LTD.
    Inventors: Karlheinz Grillitsch, Guenther Daum, Andreas Grutsch
  • Publication number: 20210301313
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Application
    Filed: March 28, 2018
    Publication date: September 30, 2021
    Inventors: Karlheinz Grillitsch, Guenther Daum, Andreas Grutsch